News

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of ...
Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...
Privacy and information commissioners from Canada and the U.K. will reveal the findings of their investigation into the 23andMe data breach.
A 23andMe booth at a genealogical event. The Canadian and British commissioners found the company did not have adequate ...
The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, ...
California says the sale of 23andMe to a nonprofit formed by the company's former CEO would skirt a state law specifically ...
Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her ...
June 13 (Reuters) - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ REGN.O offer for the DNA-testing company ...
TTAM Research Institute - 23andMe's co-founder and former CEO Anne Wojcicki's new company - is the winner in a final round of ...
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
Southwest Airlines has announced that it will be adding a cockpit-alert safety tool to almost all of its 800 aircraft. The Honeywell-designed “SmartRunway” and “SmartLanding” software warn pilots with ...